Posts in category

Clinical


Only one in four women of reproductive age who are dispensed oral retinoids are accessing PBS-listed contraception, despite teratogenic risks, according to a new Australian study While rates of oral …

The future of hospital pharmacy is “undeniably intertwined with the evolution of AI”, say academics Pharmacists should “embrace and lead the agenda” in using artificial intelligence as supportive tools to …

A look at some of the recent changes to the medicines landscape, with new products, indications and contraindications New Product Nelarabine (Nelarabine‑Reach) is a pro‑drug of the deoxyguanosine analogue ara‑G. …

Pharmacist training in women’s health and further PBS coverage for hormone therapies will help women receive better care for menopause, argues SHPA Pharmacists are “ideally placed” in both community and …

Monash University pharmacy interns will join the state’s immunisation workforce under a new secretary approval The approval, introduced by the Victorian Department of Health, means graduate pharmacists completing their internship …

Current credentialing arrangements for pharmacists have been extended into 2025. Experts in the field present a primer for medication management reviews Authors: Amy Page, Deborah Hawthorne and Brooke Shelly Pharmacists …

Should paracetamol and ibuprofen be displayed for sale where children can reach them? What about right next to chocolate bars? One stakeholder weighs in The Society of Hospital Pharmacists of …

A pharmacist expert on opioids is calling for an “urgent upscale” in harm minimisation, following two coroner’s recommendations on illicit drug use Coroners Ingrid Giles and Simon McGregor have recommended …

We look at some of the recent changes to the medicines landscape, with new products, indications and contraindications New Products Fezolinetant (Veoza) is a nonhormonal selective NK3 receptor antagonist that …

Discharge from hospital is a common reason for initiating oxycodone, study finds, but a proportion of people were still taking the drug 12 months later… About half of new oxycodone …

A raft of new scheduling decisions have been revealed, with a number of medicines set to be downscheduled, but no alteration to planned paracetamol changes A number of decisions have …

New research indicates the upscheduling of modified-release paracetamol has had no impact on rates of overdose, with calls for it to go to prescription only  A new Australian study has …